基本信息
浏览量:162
职业迁徙
个人简介
Dr. Carolyn Compton is an academic pathologist who received her MD and PhD degrees from Harvard Medical School. At ASU, she is the Chief Medical and Science Officer of the National Biomarkers Development Alliance, a member of the Biodesign Institute and the Chief Medical Officer of the Complex Adaptive Systems Initiative. Her research interests are related to colon cancer, bio-banking and biomarkers development.
She was a professor of pathology at Harvard and Massachusetts General Hospital, Chair of Pathology at McGill University from 2000-2005, and Director of the Office of Biorepositories and Biospecimen Research at the National Cancer Institute until 2012. She is the past CEO and President of the Critical Path Institute.
Compton is an adjunct professor of pathology at both the University of Arizona and Johns Hopkins, and research associate at Mayo Clinic.
Honors and Awards for Education:
Outstanding Medical Educator of the Year – University of
Massachusetts Medical School
1982。
Outstanding Medical Educator of the Year – University of
Massachusetts Medical School
1983。
Faculty Prize for Excellence in Teaching – Harvard Medical School 1990。
Faculty Prize for Excellence in Teaching – Harvard Medical School 1999。
Select Publications:
GTEx Consortium. The genotype-Tissue Expression (GTEx) Project. NatGenetics 2013;45:580-5.
Goldman M, Compton C, Mittleman BB. Public-private Partnerships as Driving Forces in the Quest for Innovative Medicines. Clin Transl Med 2013;2:2.
Mucci NR, Moore HM, Brigham LE, Goldthwaite CA, Little AR, Lockhart NC, Scott MP, Struewing JP, Vincent Sl, Compton CC, for the cancer Human Biobank (caHUB). Acquisition of Normal Tissue Subgroup, National Cancer Institute Biopreservation and Biobanking. 2013 Apr;11:77-82.
Hayes DF, Allen J, Compton C, Gustavsen G, Leonard DGB, McCormack R, Newcomer L, Pothier K, Ransohof D, Schilsky RL, Sigal E, Taube SE, Tunis SR. Breaking a Vicious cycle. Science Transl Med 2013;5:1-7.
Warren RS, Atreya CE, Niedzwiecki D, Weinberg V, Donner DB, Mayer RJ, Goldberg RM, Compton C, Zuraek MB, Ye X, Saltz LB, Bertagnolli MM. Association of TP53 Mutational Status and Gender with Survival After Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803. Clin Cancer Research 2013 Epub ahead of print.
Compton CC, Byrd DR, Garcia-Aguilar J, Kurtzman SH, Olawaiye A, Washington MK (eds). AJCC Staging Atlas. 2nd Edition. A Companion to the seventh Editions of the AJCC Staging Manual and Handbook.. New York, Springer, 2012.
研究兴趣
论文共 665 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2023)
Robert S. Warren,Chloe E. Atreya,Donna Niedzwiecki, Vivian K. Weinberg,David B. Donner,Robert J. Mayer,Richard M. Goldberg,Carolyn C. Compton, Marlene B. Zuraek, Cynthia Ye,Leonard B. Saltz,Monica M. Bertagnolli
crossref(2023)
crossref(2023)
arxiv(2022)
引用0浏览0引用
0
0
International Journal of Population Data Scienceno. 3 (2022)
Carolyn C. Compton, Angelo M. De Mario,Jayanta Debnath,Keith D. Eaton,Kojo Elenitoba-Johnson,Michelangelo Fiorentino,Christopher A. French,Thomas J. Fuchs,Felice Giangaspero,Jiaoti Huang, A. John Lafrate,Michael M. Ittmann,
CLINICAL CANCER RESEARCHno. 2 (2022): 265-270
Cancer: The Enemy from Withinpp.83-107, (2020)
Cancer: The Enemy from Withinpp.259-267, (2020)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn